Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.58
+0.06003.95%
Post-market: 1.580.00000.00%16:00 EDT
Volume:81.02K
Turnover:126.08K
Market Cap:70.13M
PE:-2.25
High:1.58
Open:1.54
Low:1.52
Close:1.52
Loading ...

ESSA Pharma Q4 2024 GAAP EPS $(0.14) Beats $(0.21) Estimate, Cash Balance Of $103.71M

Benzinga
·
17 Dec 2024

ESSA Pharma Inc Q4 Shr View $-0.20 -- Lseg Ibes Data

THOMSON REUTERS
·
17 Dec 2024

ESSA Pharma Inc: Qtrly Loss per Share $0.14

THOMSON REUTERS
·
17 Dec 2024

ESSA Pharma Inc: Strategic Review Expected to Involve Headcount and Other Cost Reductions

THOMSON REUTERS
·
17 Dec 2024

ESSA Pharma Inc: Initiated Comprehensive Process to Explore and Review a Range of Strategic Options

THOMSON REUTERS
·
17 Dec 2024

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024

THOMSON REUTERS
·
17 Dec 2024

Press Release: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024

Dow Jones
·
17 Dec 2024

ESSA Pharma Inc - Terminates License Agreement With British Columbia Cancer Agency and Ubc

THOMSON REUTERS
·
16 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
09 Dec 2024

ESSA Pharma Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
06 Dec 2024

ESSA Pharma Introduces New Executive Severance Plan

TIPRANKS
·
06 Dec 2024

ESSA Pharma And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
11 Nov 2024

BRIEF-Tang Capital Management, Llc Reports 9.7% Stake In Essa Pharma As Of Nov 1- SEC Filing

Reuters
·
09 Nov 2024

Tang Capital Management, Llc Reports 9.7% Stake in ESSA Pharma as of Nov 1- SEC Filing

THOMSON REUTERS
·
09 Nov 2024

ESSA Pharma : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
04 Nov 2024

ESSA Pharma downgraded by Oppenheimer, Piper Sandler after drug setback in trials

Investing.com
·
04 Nov 2024

Piper Sandler Downgrades ESSA Pharma to Neutral

MT Newswires Live
·
04 Nov 2024

Essa Pharma Cut to Perform From Outperform by Oppenheimer

Dow Jones
·
04 Nov 2024

Essa Pharma downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
04 Nov 2024

ESSA Pharma Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2 From $15

THOMSON REUTERS
·
04 Nov 2024